Andrew Cannon (CCE's CFO) says the following:
There is no underlying reason behind the share
price movement other than general market weakness and tax loss selling
may well be having an impact. CellSpray continues to be used in Europe
(we are focusing on Germany) with good outcomes and hospitals are
reordering the product which indicates they are happy with the outcomes.
As we have stated we will be concentrating on key approved markets to
generate the sales forecasts we announced in March.
Kind regards
Andrew
Andrew Cannon Chief Financial Officer
Clinical Cell Culture
13 - 15 Hills Road, Cambridge CB2 1NL
- Forums
- ASX - By Stock
- uk recell trial
Andrew Cannon (CCE's CFO) says the following:There is no...
-
-
- There are more pages in this discussion • 3 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add CCE (ASX) to my watchlist
(20min delay)
|
|||||
Last
3.8¢ |
Change
-0.001(2.56%) |
Mkt cap ! $13.91M |
Open | High | Low | Value | Volume |
3.9¢ | 4.0¢ | 3.8¢ | $2.541K | 64.67K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
3 | 44046 | 3.8¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
3.9¢ | 10684 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
3 | 44046 | 0.038 |
3 | 219628 | 0.037 |
3 | 248333 | 0.036 |
3 | 243500 | 0.035 |
2 | 229441 | 0.034 |
Price($) | Vol. | No. |
---|---|---|
0.039 | 10684 | 1 |
0.040 | 393495 | 4 |
0.041 | 18119 | 4 |
0.042 | 10423 | 2 |
0.043 | 50000 | 1 |
Last trade - 15.19pm 13/09/2024 (20 minute delay) ? |
Featured News
CCE (ASX) Chart |
The Watchlist
LPM
LITHIUM PLUS MINERALS LTD.
Simon Kidston, Non--Executive Director
Simon Kidston
Non--Executive Director
SPONSORED BY The Market Online